Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Small. 2014 Nov 10;11(13):1592–1602. doi: 10.1002/smll.201402184

Figure 3.

Figure 3

NP labeling strategy for PS and GM1. a) PS or GM1 are labeled using AnxV or CTB in combination with Biotin-Neutravidin binding chemistries. b) TEM images of fixed and negatively-stained VLPs after NP binding to PS. Scale bars are 40 nm. c) Relative Labeling efficiencies for different lipid-VLP combinations: PS-WT; PS-29/31KE, GM1-WT and control (lacking AnxV and CTB).